Men | Women | |||
---|---|---|---|---|
MS not present (n = 36) | MS present (n = 33) | MS not present (n = 47) | MS present (n = 28) | |
Age | 52.3 ± 9.5 | 51.6 ± 8.0 | 48.6 ± 7.2 | 52.9 ± 7.9* |
BMI, kg/m2 | 26.4 ± 3.1 | 29.8 ± 3.7$ | 26 ± 4.5 | 31.3 ± 4.5^ |
WC, cm | 93.8 ± 8.5 | 103.5 ± 8.3$ | 83.4 ± 9.5 | 96.8 ± 6.5^ |
SBP#, mmHg. | 135 (128–152) | 146 (135–157)* | 128 (119–136) | 140 (134–160)& |
DBP#, mmHg. | 89 (81–96) | 93 (89–102)** | 83 (77–91) | 91 (80–96) |
TC, mmol/L | 5.1 ± 0.9 | 5.5 ± 0.9 | 5.02 ± 0.9 | 4.97 ± 1.3 |
TG#, mmol/L | 1.2 (0.9–1.4) | 2.2 (1.7–3.5)^ | 1.0 (0.8–1.2) | 1.5 (1.1–2.0)$ |
HDL-C#, mmol/L | 1.15 (1.02–1.4) | 0.83 (0.7–1.0)^ | 1.4 (1.3–1.6) | 1.03 (0.8–1.2)^ |
LDL-C, mmol/L | 3.2 ± 0.8 | 3.4 ± 0.9 | 3.1 ± 0.8 | 3.2 ± 1.03 |
Glucose#, mmol/L | 5.2 (5.04–5.4) | 6.2 (5.7–6.6)^ | 5.2 (4.9–5.5) | 5.8 (5.5–6.3)^ |
Smoking, n (%) | 15 (41.7) | 11 (33.3) | 0 (0) | 0 (0) |
AH, n (%) | 18 (50) | 27 (81.8)* | 12 (25.5) | 18 (64.3)** |
Dyslipidemia, n (%) | 12 (33.3) | 32 (96.7)^ | 14 (29.8) | 27 (96.4)^ |
Hyperglycemia, n (%) | 5 (13.9) | 25 (75.8)^ | 7 (14.9) | 20 (71.4)^ |
IMT#, mm | 0.72 ± 0.01 | 0.78 ± 0.01 | 0.66 ± 0.009 | 0.72 ± 0.01* |